inclusion criteria: 1. age at least 18 years 2. ability and willingness of participant or legally authorized representative (lar) to give written informed consent. 3. laboratory confirmed diagnosis of infection with sars-cov-2 by pcr 4. hospitalized for covid-19 with one or more respiratory or gastrointestinal (gi) symptoms: * covid-19 associated respiratory symptoms include but are not limited to: cough, shortness of breath, difficulty breathing, or sore throat * covid-19 associated gi symptoms include but are not limited to: loss of taste, loss of sense of smell, diarrhea, nausea, or vomiting, note: respiratory and gi symptoms other than those listed above, must be noted as acceptable and signed by study pi or designee.

inclusion criteria: 1. age at least 18 years 2. ability and willingness of participant or legally authorized representative (lar) to give written informed consent. 3. laboratory confirmed diagnosis of infection with sars-cov-2 by pcr 4. hospitalized for covid-19 with one or more respiratory or gastrointestinal (gi) symptoms: * covid-19 associated respiratory symptoms include but are not limited to: cough, shortness of breath, difficulty breathing, or sore throat * covid-19 associated gi symptoms include but are not limited to: loss of taste, loss of sense of smell, diarrhea, nausea, or vomiting, note: respiratory and gi symptoms other than those listed above, must be noted as acceptable and signed by study pi or designee.

inclusion criteria: age at least 18 years ability and willingness of participant or legally authorized representative (lar) to give written informed consent. laboratory confirmed diagnosis of infection with sars-cov-2 by pcr hospitalized for covid-19 with one or more respiratory or gastrointestinal (gi) symptoms: covid-19 associated respiratory symptoms include but are not limited to: cough, shortness of breath, difficulty breathing, or sore throat covid-19 associated gi symptoms include but are not limited to: loss of taste, loss of sense of smell, diarrhea, nausea, or vomiting, note: respiratory and gi symptoms other than those listed above, must be noted as acceptable and signed by study pi or designee.

inclusion criteria: age at least 18 years ability and willingness of participant or legally authorized representative (lar) to give written informed consent. laboratory confirmed diagnosis of infection with sars-cov-2 by pcr hospitalized for covid-19 with one or more respiratory or gastrointestinal (gi) symptoms: covid-19 associated respiratory symptoms include but are not limited to: cough, shortness of breath, difficulty breathing, or sore throat covid-19 associated gi symptoms include but are not limited to: loss of taste, loss of sense of smell, diarrhea, nausea, or vomiting, note: respiratory and gi symptoms other than those listed above, must be noted as acceptable and signed by study pi or designee.

inclusion criteria: 1. age at least 18 years 2. ability and willingness of participant or legally authorized representative (lar) to give written informed consent. 3. laboratory confirmed diagnosis of infection with sars-cov-2 by pcr 4. hospitalized for covid-19 with one or more respiratory or gastrointestinal (gi) symptoms: - covid-19 associated respiratory symptoms include but are not limited to: cough, shortness of breath, difficulty breathing, or sore throat - covid-19 associated gi symptoms include but are not limited to: loss of taste, loss of sense of smell, diarrhea, nausea, or vomiting, note: respiratory and gi symptoms other than those listed above, must be noted as acceptable and signed by study pi or designee.

inclusion criteria: 1. age at least 18 years 2. ability and willingness of participant or legally authorized representative (lar) to give written informed consent. 3. laboratory confirmed diagnosis of infection with sars-cov-2 by pcr 4. hospitalized for covid-19 with one or more respiratory or gastrointestinal (gi) symptoms: - covid-19 associated respiratory symptoms include but are not limited to: cough, shortness of breath, difficulty breathing, or sore throat - covid-19 associated gi symptoms include but are not limited to: loss of taste, loss of sense of smell, diarrhea, nausea, or vomiting, note: respiratory and gi symptoms other than those listed above, must be noted as acceptable and signed by study pi or designee.